「引人入勝……擁有電影場景般的細節……」——《科學 Science》

▲Theranos公司創始人Elizabeth Holmes

她，被譽為“女版喬布斯”

用“一滴血”顛覆血液檢測、翻轉醫療產業

短短十年，成為硅谷首位身價數十億美元的女性科技創業家

然而，一個爆料、一封匿名檢舉信，一位《華爾街日報》調查記者，

在六個月內，卻使這高達90億美元的生物科技獨角獸極速崩解……

在本書中，作者John Carreyrou揭露了繼“安然事件”之後規模極為龐大的企業詐欺案件，講述了一個關於野心與被利益矇蔽雙眼的故事。

The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.

A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.

圖 | Theranos的產品nanotainers

生物科技新創公司Theranos宣稱，自家公司研發的機器只需要幾滴血，就可以驗出許多種疾病，此研究推翻了過往血液測量的方式。與傳統的血液檢測動輒數百美元的花費相比，Theranos只需要2.99美元。

社會各界對於這一“顛覆性”創新十分看好，各種頭銜紛至沓來：女版“喬布斯”、美女創業者，2014年底，公司的估值達90億美元，Theranos被評為僅次於特斯拉的“改變世界的創業公司”。

似乎，這一局Theranos穩贏了。但一切的美夢都隨着《華爾街日報》的調查報告而變得粉碎，Holmes的傳奇故事戛然而止……

John Carreyrou

《華爾街日報》調查記者，曾兩度獲得普利策獎（Pulitzer Prize）。 

他對Theranos的深入報導，獲得了喬治·波克獎（George Polk Award）財經報導獎項、羅布傑出商業財經新聞獎（Gerald Loeb Award for Distinguished Business and Financial Journalism）的專題報導獎項，以及巴萊特&史提爾調查新聞銀獎（Barlett & Steele Silver Award for Investigative Business Journalism）。